Login / Signup

Disruption of CCL2 in Mesenchymal Stem Cells as an Anti-Tumor Approach against Prostate Cancer.

Quoc Thang BuiKuan-Der LeeYu-Ching FanBranwen S LewisLih-Wen DengYuan-Chin Tsai
Published in: Cancers (2023)
Disruption of MSC-derived CCL2 enhances anti-tumor functions in an immune-competent syngeneic mouse model for prostate cancer.
Keyphrases
  • prostate cancer
  • mesenchymal stem cells
  • radical prostatectomy
  • mouse model
  • liver fibrosis
  • liver injury
  • umbilical cord
  • bone marrow
  • drug induced
  • stem cells